TobaccoReporter logo

Tag: Turning Point

  • Turning Point Reports Record Q3 2025

    Turning Point Reports Record Q3 2025

    Turning Point Brands, Inc. reported Q3 2025 net sales up 31.2% year-over-year to $119 million, driven by strong performance in its Modern Oral segment, which surged 627.6% to $36.7 million, now representing 31% of total sales. Adjusted EBITDA rose 17.2% to $31.3 million, and net income jumped 70.3% to $21.1 million. The company raised its 2025 Adjusted EBITDA outlook to $115–120 million (from $110–114 million) and increased Modern Oral sales guidance to $125–130 million (from $100–110 million).

    CEO Graham Purdy said the results “exceeded expectations,” highlighting the strong growth of Modern Oral products and progress toward qualifying U.S. white pouch production lines by early 2026. The Stoker’s segment grew 80.8% to $74.8 million, while the Zig-Zag segment declined 10.5% to $44.2 million. TPB ended the quarter with $201 million in cash and $267.8 million in total liquidity.

  • Turning Point Reports Strong Q3 2025

    Turning Point Reports Strong Q3 2025

    Turning Point Brands, Inc. posted third-quarter 2025 net sales of $119.0 million, up 31.2% year-over-year, driven by Stoker’s segment growth of 80.8%. Gross profit rose 39.7% to $70.4 million, while net income increased 70.3% to $21.1 million, the company said today (November 5).

    The company highlighted Modern Oral sales of $36.7 million, up 628% from last year, with U.S. white pouch production lines expected to qualify in H1 2026. The Zig-Zag segment saw a 10.5% decline, mainly due to the Clipper business wind-down.

    TPB ended Q3 with $201.2 million in cash, total liquidity of $267.8 million, and net debt of $98.8 million. The company raised $97.5 million through its ATM offering to accelerate Modern Oral growth.

    For full-year 2025, TPB raised Adjusted EBITDA guidance to $115–120 million and Modern Oral sales forecast to $125–130 million.

  • Tobacco Stocks Stumble as ‘PMI Results Weigh on Sector’

    Tobacco Stocks Stumble as ‘PMI Results Weigh on Sector’

    Tobacco and nicotine stocks slipped yesterday (October 24) as shares of Philip Morris International fell following the company’s third-quarter results. While the company reported stronger-than-expected earnings and revenue, investors reacted negatively to a modest increase in full-year profit guidance and concerns over slowing growth in its smoke-free division. PMI shares dipped around 3–4% after the announcement, according to MSN’s Seeking Alpha.

    The sentiment rippled across the sector, pulling down other major players, according to Seeking Alpha. British American Tobacco traded about 2% lower, Turning Point Brands dropped nearly 4%, and Greenlane Holdings fell more than 5%. Altria Group also edged down around 1.5% ahead of its own quarterly earnings report, expected next week.

    Analysts at Morgan Stanley and BofA Securities maintained their “buy” ratings on Philip Morris, emphasizing its strong growth potential in reduced-risk products such as Zyn nicotine pouches. However, market watchers noted that investor expectations remain high even as the industry faces regulatory scrutiny and shifting consumer trends. The broader tobacco sector continues to balance solid cash flow and dividend stability against slower growth and rising public health pressures.

  • Turning Point to Host Q3 Call on November 5

    Turning Point to Host Q3 Call on November 5

    Turning Point Brands, Inc. announced it will host a conference call November 5 at 8:30 a.m. EST to review Q3 2025 results. Listeners in the U.S. can call 800 715-9871, while international listeners call +1 646 307-1963. The event ID is 6640134.

    Participants should call at least 10 minutes in advance and follow the audio prompts to register. The call will also be broadcast live as a listen-only webcast from the investor relations section of the company’s website. The replay of the webcast will be available on the site two hours following the call.

  • FDA Launches Pilot to Fast-Track Nicotine Pouch Reviews

    FDA Launches Pilot to Fast-Track Nicotine Pouch Reviews

    The U.S. Food and Drug Administration is set to fast-track reviews of nicotine pouches from Philip Morris International, Altria, Reynolds American, and Turning Point Brands in a pilot program launching Monday, according to Reuters. According to transcripts of an agency meeting last Friday, the agency aims to complete assessments by December, providing a quicker path to market for products like Zyn, on!, Velo, Fre, and Alp. The initiative comes amid pressure from the Trump administration to accelerate approvals and streamline the review process for the fastest-growing category of U.S. tobacco alternatives.

    The pilot program will reportedly feature reduced and expedited reviews, more frequent communication between FDA staff and companies, and a focus on essential scientific and safety data, including product characterization, manufacturing consistency, and abuse-liability information. For products already on the market without full authorization, the process could remove uncertainty over legality and potential enforcement actions. Tobacco firms have long lobbied for a faster FDA authorization route, noting that lengthy reviews have allowed competitors to capture market share in the meantime.

    “Adult nicotine and tobacco consumers are increasingly seeking nicotine pouches as a smoke-free alternative, and the industry is rapidly growing in response,” said Laura Leigh Oyler, vice president of U.S. Regulatory Affairs at Haypp Group, who will be speaking at GTNF 2025 in Brussels on the U.S. regulatory landscape. “These consumers deserve a marketplace of FDA-reviewed product choices to support their journey away from more harmful products. 

    “It makes sense that our government should also work to meet the demands of citizens, supporting a regulatory regime that quickly reviews well-designed and well-tested products from responsible and compliant manufacturers. This is a positive step not just for the regulator and the regulated industry, but for the millions of American adults looking for products they can trust.”

  • Stoker’s Rolls Out Fine Cut Wintergreen in New Can Format

    Stoker’s Rolls Out Fine Cut Wintergreen in New Can Format

    Stoker’s introduced its Fine Cut Wintergreen in a 1.2-ounce can, now available in 15 states. The product, previously sold only in 12-ounce tubs, “brings the same smooth flavor and consistent quality in a portable, on-the-go format,” the company said. “Consumers have been asking for a Fine Cut Wintergreen can, and we listened,” said Thomas Helms III, senior brand director.

    The launch expands Stoker’s moist smokeless tobacco portfolio and gives retailers new growth opportunities, with internal data showing stores that carry both cans and tubs see up to fivefold higher sales. A nationwide rollout is planned through 2025.

  • Modern Oral Sales Surge 651% in Turning Point’s Strong Q2 Report

    Modern Oral Sales Surge 651% in Turning Point’s Strong Q2 Report

    Turning Point Brands, Inc. reported robust second-quarter results, with Modern Oral net sales skyrocketing 651% Y-Y to $30.1 million, now making up 26% of total revenue. Total net sales rose 25.1% to $116.6 million, while net income increased 11.3% to $14.5 million. Adjusted EBITDA grew 14.8% to $30.5 million, and adjusted net income hit $18 million.

    The Stoker’s segment, boosted by Modern Oral, posted a 62.9% sales increase, while Zig-Zag declined 6.9% due to product mix shifts. Despite that, the company increased its full-year 2025 Modern Oral sales forecast to $100–110 million, up from $80–95 million.

    CEO Graham Purdy credited the strong results to aggressive growth in Modern Oral and resilience in legacy brands. “Our consolidated second quarter results were better than expected,” he said.

    TPB ended the quarter with $190.1 million in net debt and $176.4 million in liquidity. The company also raised its 2025 Adjusted EBITDA guidance to $110–114 million.

    A replay of the earnings call can be found at turningpointbrands.com.

    The company also declared a regular quarterly dividend of $0.075 per common share. The dividend is payable October 10, to shareholders of record on the close of business on September 19.

  • Zig-Zag Introduces Value-Priced, High-Turnover Line  

    Zig-Zag Introduces Value-Priced, High-Turnover Line  

    Zig-Zag launched itsWoods brand, a new line of premium natural leaf cigars designed to meet rising demand in the rough-cut segment. Many consumers refer to rough-cut cigars as “woods.”

    “Zig-Zag Woods features a slow-burning, all-natural leaf wrap filled with premium rough-cut tobacco, delivering a rich and smooth smoking experience,” the company said. “With bold flavor profiles and recognizable Zig-Zag branding, this line is engineered for fast sell-through and high margins.”

    The cigars will be offered in five flavors and be pre-priced at $1.39 for two sticks. They will be sold in 15-pouch cartons and 24-carton cases, “ready to hit retail shelves with high-margin potential.”

  • FRE Announces Partnership with PBR Tour

    FRE Announces Partnership with PBR Tour

    FRE Nicotine Pouches (part of Turning Point Brands) announced its largest sports sponsorship to date in becoming an official, multi-year partner of the Professional Bull Riders (PBR) Unleash the Beast tour, the sport’s top individual series.

    “Professional bull riding delivers the most exciting eight seconds in sports, and we’re thrilled to be part of that energy through our title sponsorship of the Unleash The Beast,” said Connor Smith, VP of Marketing for FRE. “PBR’s viewership has been steadily rising, and the sport is selling out iconic venues coast to coast – that’s the kind of passionate, engaged audience that aligns perfectly with FRE’s innovative approach to nicotine. Our PBR partnership represents more than just sponsorship; it’s about connecting with fans who appreciate authenticity, seizing the moment, and pushing boundaries.”

    FRE made its rodeo debut at Kid Rock’s Rock N Rodeo and the PBR World Finals in May. At the Championship event, FRE helped launch the “FRE Challenge Button,” allowing riders to request video reviews—a first in PBR history.

  • Turning Point Announces 1Q YoY Increase of 28.1%

    Turning Point Announces 1Q YoY Increase of 28.1%

    Turning Point Brands, Inc. today (May 7) announced financial results for the first quarter ended March 31, with net sales increasing 28.1% YoY to $106.4 million.

    “We are pleased with our first quarter results,” said Graham Purdy, President and CEO. “Modern Oral sales were $22.3 million, up nearly 10 times versus the prior year and nearly double the prior quarter. MST and looseleaf exceeded our expectations, and Zig-Zag was in line with our expectations.”

    The announcement included a Q1 2025 Adjusted EBITDA of $27.7 million, up 12.0% over the prior year, and a reaffirmation of previously announced 2025 Adjusted EBITDA guidance of $108 million to $113 million; increasing full-year consolidated nicotine pouch sales guidance to a range of $80 million to $95 million, from $60 million to $80 million.

    The company said Stoker’s Products net sales increased 62.7%; Zig-Zag Products net sales increased 1.2%; and gross profit increased 23.3% to $59.6 million.